What Will Thermo Fisher Scientific and Life Technologies $14 billion Merger hold for the Top Ten Suppliers of Synthetic Biology Technology and DNA Sequencing Landscape?

FARMINGTON, Conn., April 15, 2013 /PRNewswire-iReach/ -- Life Technologies, one of the top ten suppliers of synthetic biology technology, recently merged with Thermo Fisher Scientific. The lab equipment company bought Life Technologies for $13.6 billion in cash and $2.2 billion in debt. What are the implications this merger has for the DNA sequencing industry? In a recent Forbes story, Matthew Herper reports "As a result of all of this competition and new technologies, DNA sequencing has gotten cheaper with incredible speed. In 2007, it cost $1 million to create a human genome. Now some insurers have reimbursed doctors about $20,000 for sequencing all of a patient's DNA."

(Photo: http://photos.prnewswire.com/prnh/20130415/CG94866)

Top Ten Suppliers of Synthetic Biology Technology

The recent merger between Thermo Fisher Scientific and Life Technologies means changes in the landscape for the rest of the nine leading suppliers of synthetic biology technology – DNA2.0, Origene, Synthetic Genomics, DuPont, Pfizer, Novozymes, Amrys Biotechnologies, Scarab Genomics, and British Petroleum – profiled in BCC Research's recently published report. The document examines these top companies in the field and discusses their positions in these complex patterns of supply and demand, as well as their investments and alliances.

Intense research and development continues to be both privately and publically funded, but the work has emphatically moved out of the laboratory and into the marketplace. Major corporations are putting new intellectual properties to work in new factories in the U.S. and abroad.

The players on this new field include new companies that come directly out of university research riding large holdings of intellectual property and established multinational giants that have the networks necessary to distribute and market the new materials.

Between these two ends of the spectrum, companies are emerging that can intermediately supply the substances and services that bridge the gaps. The result is intricate patterns of interconnection between layers of the new supply chains. Acquisitions up and down these supply chains are frequent, as capital is freely available due to the obvious potential.

More information about this report and a free sample are available at http://www.giiresearch.com/report/bc264062-top-ten-suppliers-synthetic-biology-technology.html

Global DNA Sequencing Products Market 2012-2016

The global DNA sequencing product market is expected to grow at a compound annual rate of 18.48 percent between 2012 and 2016. One of the key factors contributing to this market growth is the introduction of whole genome sequencing. The Global DNA Sequencing Products market has also been witnessing an increase in the number of DNA sequencing projects. However, the low adoption of genomic technology could pose a challenge to the growth of this market.

More information about this report and a free sample are available at http://www.giiresearch.com/report/infi260049-global-dna-sequencing-products-market.html

DNA sequencing

technologies, markets and companies

In this report, Jain Pharmabiotech briefly reviews basics of human genome variations, development of sequencing technologies, and their applications. Current large and small sequencers are described as well as companies developing them. Various applications of DNA sequencing are described including those for genetics, medical diagnostics, drug discovery and cancer. Next generation sequencing technologies, both second and third generations, are reviewed. Companies developing software for analysis of sequencing data are also included. Selected academic institutes conducting research in sequencing are also listed.

More information about this report and a free sample are available at http://www.giiresearch.com/report/jai84243-dna-sequ-tech.html

Find more market research for the Biotechnology industry

With nearly 30 years of market research experience, Global Information, Inc (GII) is the single best resource for companies entering new markets, expanding their business, and securing their positions in their respective industries. With tens of thousands of reports from over 400 publishers in nearly every vertical market, our market research and forecast data can give companies the edge they need to stay ahead of the competition and plan for every contingency.

The reports above are just a few examples from the hundreds of research reports we have available for the biotechnology market. For a free consultation on the market research you need, contact us today!

About Global Information Inc. Global Information (GII) (http://www.giiresearch.com) is an information service company partnering with over 300 research companies around the world. Global Information has been in the business of distributing technical and market research for more than 25 years. Expanded from its original headquarters in Japan, Global Information now has offices in Korea, Taiwan, Singapore, Europe and the United States.

Media Contact: Jeremy Palaia Global Information, Inc., 1-860-674-8796, Press@gii.co.jp

News distributed by PR Newswire iReach: https://ireach.prnewswire.com

SOURCE Global Information, Inc.



RELATED LINKS
http://www.giiresearch.com

More by this Source

View all news by Global Information, Inc.

Custom Packages

Browse our custom packages or build your own to meet your unique communications needs.

Start today.

 

PR Newswire Membership

Fill out a PR Newswire membership form or contact us at (888) 776-0942.

Learn about PR Newswire services

Request more information about PR Newswire products and services or call us at (888) 776-0942.